Opinion|Videos|January 28, 2025
Streamlining Transitions Between Academic and Community Centers
Author(s)Jeffrey V. Matous, MD
Jeffrey V. Matous, MD, discusses how telehealth and remote monitoring can enhance the safe administration of bispecific antibody therapies in community settings, especially for rural or underserved populations, while emphasizing the importance of communication and collaboration between academic and community practices to improve delivery and coordination of care.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How can telehealth and remote monitoring, including tools for managing CRS or other toxicities, support the safe administration of bispecific antibody therapies in community settings while expanding access for rural or underserved populations?
- How can academic and community practices strengthen communication and collaboration to support the delivery of bispecific antibody therapies, and what tools or frameworks might facilitate this coordination?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
2
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
3
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
4
Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD
5
